What is the risk of not performing comprehensive NGS molecular profiling, and relying exclusively on more targeted panels? What might we miss?

What is the risk of not performing comprehensive NGS molecular profiling, and relying exclusively on more targeted panels? What might we miss?

What is the risk of not performing comprehensive NGS molecular profiling, and relying exclusively on more targeted panels? What might we miss?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Lia Tsimberidou, MD, PhD

Lia Tsimberidou, MD, PhD

Tenured Associate Professor
Department of Investigational Cancer Therapeutics
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX